HLNE

Hamilton Lane Inc

Add to Watchlist

Advanced Chart

155.630

+3.08(2.019%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

155.630

Open

155.630

VWAP

155.63

Vol

822.00

Mkt Cap

8.49B

Low

155.630

Amount

127.93K

EV/EBITDA(TTM)

26.16

Total Shares

40.53M

8.70B

EV/OCF(TTM)

24.86

P/S(TTM)

10.92

Hamilton Lane Incorporated is a private markets investment company providing solutions to institutional and private wealth investors around the world. The Company offers a variety of investment solutions to address its clients’ needs across a range of private markets, including private equity, private credit, real estate, infrastructure, real assets, growth equity, venture capital and impact. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct investments alongside such funds and acquisitions of secondary stakes in such funds, with a number of its clients utilizing multiple investment types. These solutions are offered in a variety of formats, covering some or all phases of private markets investment programs, which include customized separate accounts, specialized funds, advisory services, distribution management, and reporting, monitoring, data and analytics.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q2

FY2026Q3

FY2026Q4

176.71M

+17.81%

1.168

+9.16%

187.29M

+11.31%

1.264

+1.12%

194.38M

-1.82%

1.294

+6.94%

Estimates Revision

The market is revising Upward the revenue expectations for Hamilton Lane Incorporated (HLNE) for FY2026, with the revenue forecasts being adjusted by 0.88% over the past three months. During the same period, the stock price has changed by -10.01%.

Revenue Estimates for FY2026

Revise Upward

+0.88%

In Past 3 Month

EPS Estimates for FY2026

Revise Downward

-5.35%

In Past 3 Month

Stock Price

Go Down

-10.01%

In Past 3 Month

6 Analyst Rating

-1.56% Downside

Wall Street analysts forecast HLNE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLNE is 153.20 USD with a low forecast of 136.00 USD and a high forecast of 168.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

4 Hold

1 Sell

Hold

-1.56% Downside

Current: 155.630

Low

136.00

Averages

153.20

High

168.00

-1.56% Downside

Current: 155.630

Low

136.00

Averages

153.20

High

168.00

Keefe Bruyette

Market Perform

upgrade

$160 -> $175

2025-08-06

Reason

Keefe Bruyette

Price Target

$160 -> $175

2025-08-06

upgrade

Market Perform

Reason

Keefe Bruyette raised the firm's price target on Hamilton Lane to $175 from $160 and keeps a Market Perform rating on the shares. The firm upped estimates post the company's fiscal Q1 report on higher fee related performance fees.

Keefe Bruyette

Market Perform

downgrade

$162 -> $155

2025-06-02

Reason

Keefe Bruyette

Price Target

$162 -> $155

2025-06-02

downgrade

Market Perform

Reason

Keefe Bruyette lowered the firm's price target on Hamilton Lane to $155 from $162 and keeps a Market Perform rating on the shares. Hamilton Lane reported a performance fee-driven beat in Q4, the analyst tells investors in a research note.

Wells Fargo

Equal Weight

downgrade

$166 -> $161

2025-05-30

Reason

Wells Fargo

Price Target

$166 -> $161

2025-05-30

downgrade

Equal Weight

Reason

Wells Fargo lowered the firm's price target on Hamilton Lane to $161 from $166 and keeps an Equal Weight rating on the shares. The firm says that recent strength set a high bar, and Q4 was not as bad as the stock reaction, though seeing through some noisy elements was a challenge. Yet, decelerating fee AUM and unclear FRPR path might lead investors to "wait and see," Wells adds.

Outperform -> Perform

downgrade

2025-05-15

Reason

Price Target

2025-05-15

downgrade

Outperform -> Perform

Reason

Oppenheimer downgraded Hamilton Lane to Perform from Outperform.

Oppenheimer

Outperform -> Perform

downgrade

2025-05-15

Reason

Oppenheimer

Price Target

2025-05-15

downgrade

Outperform -> Perform

Reason

As previously reported, Oppenheimer downgraded Ares Management (ARES) and Hamilton Lane (HLNE) to Perform from Outperform as price targets are exceeded. The firm notes that it is not changing any earnings estimates, but rather just adjusting its valuation models to account for the market moves.

Morgan Stanley

Michael Cyprys

Hold

Maintains

$190 → $157

2025-04-14

Reason

Morgan Stanley

Michael Cyprys

Price Target

$190 → $157

2025-04-14

Maintains

Hold

Reason

Morgan Stanley analyst Michael Cyprys lowered the firm's price target on Hamilton Lane to $157 from $190 and keeps an Equal Weight rating on the shares. The firm reduced price targets by 24% on average across the alternative asset manager group on 10% lower FY26 EPS forecasts on average as well as lower P/E multiples given the view that "sluggish" capital markets raise risks to the "private markets flywheel."

See All Ratings

Valuation Metrics

The current forward P/E ratio for Hamilton Lane Inc (HLNE.O) is 30.02, compared to its 5-year average forward P/E of 26.46. For a more detailed relative valuation and DCF analysis to assess Hamilton Lane Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

26.46

Current PE

30.02

Overvalued PE

31.65

Undervalued PE

21.28

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

17.10

Current EV/EBITDA

20.17

Overvalued EV/EBITDA

20.49

Undervalued EV/EBITDA

13.71

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

7.64

Current PS

8.81

Overvalued PS

9.35

Undervalued PS

5.92